Pila Pharma AB (FRA:5KC) Pretax Margin %: -4,692.00% (As of Dec. 2025)


FRA:5KC Pila Pharma AB FRA:5KC
49 GF Score
Price €0.10
GF Value €0.15
! 3 Warning Signs
View Full Analysis

What is Pila Pharma AB Pretax Margin %?

Pila Pharma AB FRA:5KC -3.24% 49 Pretax Margin % is -4,692.00% as of Dec. 2025. GuruFocus rates FRA:5KC with a GF Score™ of 49/100 and a GF Value™ of €0.15. The stock has 3 warning signs investors should review. Among 940 Biotechnology companies, Pila Pharma AB ranks worse than 82.23% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Pila Pharma AB's Pre-Tax Income for the six months ended in Dec. 2025 was €-1.17 Mil. Pila Pharma AB's Revenue for the six months ended in Dec. 2025 was €0.03 Mil. Therefore, Pila Pharma AB's pretax margin for the quarter that ended in Dec. 2025 was -4,692.00%.

The historical rank and industry rank for Pila Pharma AB's Pretax Margin % or its related term are showing as below:

FRA:5KC' s Pretax Margin % Range Over the Past 10 Years
Min: -2505.49   Med: -1479.53   Max: -678.74
Current: -1496.27


FRA:5KC's Pretax Margin % is ranked worse than
82.23% of 940 companies
in the Biotechnology industry
Industry Median: -89.895 vs FRA:5KC: -1496.27

Pila Pharma AB  (FRA:5KC) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Pila Pharma AB Pretax Margin % Related Terms


Pila Pharma AB Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Pila Pharma AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pila Pharma AB Pretax Margin % Chart

Pila Pharma AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial -2,392.86 -1,424.56 -677.86 -1,458.21 -1,501.92

Pila Pharma AB Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -766.67 -613.56 -6,911.11 -483.12 -4,692.00

FRA:5KC vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Pila Pharma AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pila Pharma AB Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pila Pharma AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Pila Pharma AB's Pretax Margin % falls into.


FRA:5KC
49GF Score
Pila Pharma AB FRA:5KC
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pila Pharma AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Pila Pharma AB's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.562/0.104
=-1,501.92 %

Pila Pharma AB's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.173/0.025
=-4,692.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -4,692.00% mean?
Pila Pharma AB (FRA:5KC) has a Pretax Margin % of -4,692.00% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pila Pharma AB and its competitors. According to the industry distribution chart, Pila Pharma AB ranks #773 out of 940 companies in the Biotechnology industry, placing it in the top 82.2%.
Is Pila Pharma AB's Pretax Margin % too high?
Pila Pharma AB's current Pretax Margin % is -4,692.00%. Based on the distribution chart, Pila Pharma AB ranks #773 out of 940 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pila Pharma AB has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Pila Pharma AB's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pila Pharma AB ranks #773 out of 940 companies for Pretax Margin %. This places Pila Pharma AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pila Pharma AB and its competitors. Pila Pharma AB's current Pretax Margin % is -4,692.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pila Pharma AB stock overvalued right now?
Pila Pharma AB (FRA:5KC) has a current Pretax Margin % of -4,692.00%. The stock's GF Value™ is €0.15, compared to a current price of €0.10 — trading 30.3% below its estimated fair value. The current Pretax Margin % is -4,692.00%. Pila Pharma AB's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Pila Pharma AB (FRA:5KC), the current Pretax Margin % is -4,692.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pila Pharma AB (FRA:5KC) Overvalued in 2026?

Based on GuruFocus' analysis, Pila Pharma AB stock appears to be undervalued. The current stock price of €0.10 is trading 30.3% below its estimated GF Value™ of €0.15.

Key valuation signals for FRA:5KC:

  • Pretax Margin %: -4,692.00%
  • GF Value™: €0.15 vs. price of €0.10 (30.3% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the FRA:5KC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pila Pharma AB Business Description

Other Exchanges PILA:Sweden
Address Norra Vallgatan 72, Malmo, SWE, 211 21
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
49GF Score

Get the complete analysis for FRA:5KC

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.15
GF Value